Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Experience with donanemab over a 1-year period: observations of side effects and compliance from a regional specialty medical center.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: December 31, 2025
Lecanemab over a two-year duration: Key insights from a regional specialty medical center.
Journal: The journal of prevention of Alzheimer's disease
Published: October 08, 2025
Lecanemab over a two-year duration: Key insights from a regional specialty medical center.
Journal: The journal of prevention of Alzheimer's disease
Published: October 08, 2025
An unusual case of hereditary nephrogenic diabetes insipidus (HNDI) affecting mother and daughter.
Journal: Journal of pediatric endocrinology & metabolism : JPEM
Published: April 24, 2015
Showing 1-4 of 4
Last Updated: 09/26/2026